A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of Escalating Doses of RP-1127 (Glyburide for Injection) in Healthy Male and Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2010
At a glance
- Drugs Glibenclamide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 01 Jun 2010 New trial record